Sort   by:  
 Page size 
UnknownOverall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.
Not available
S-EPMC10207856 | biostudies-literature
UnknownAdjuvant Olaparib for Patients with <i>BRCA1</i>- or <i>BRCA2</i>-Mutated Breast Cancer.
Not available
S-EPMC9126186 | biostudies-literature
UnknownThe trans-ancestral genomic architecture of glycemic traits.
Not available
S-EPMC7610958 | biostudies-literature
UnknownPrediction of disability-free survival in healthy older people.
Not available
S-EPMC9213595 | biostudies-literature
UnknownEffect of Aspirin on Disability-free Survival in the Healthy Elderly.
Not available
S-EPMC6426126 | biostudies-literature
UnknownEffect of Aspirin on All-Cause Mortality in the Healthy Elderly.
Not available
S-EPMC6433466 | biostudies-literature
UnknownEffect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.
Not available
S-EPMC6289056 | biostudies-literature
UnknownPathogenic Germline Variants in 10,389 Adult Cancers.
Not available
S-EPMC5949147 | biostudies-literature
UnknownGenomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas.
Not available
S-EPMC5961503 | biostudies-literature
UnknownIntegrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types.
Not available
S-EPMC5916807 | biostudies-literature
Sort   by:  
 Page size